Big biotech, Biotech, M&A, Medical device, Pharma

Merger & acquisition between Baxter and Chatham Therapeutics

Posted on 03 April 2014

Tags: , , , , ,

Baxter International has agreed for merger & acquisition for Chatham Therapeutics for $70 million.

Baxter will acquire all of Chatham’s outstanding membership interests.

As a result of the transaction, Baxter will acquire Chatham’s developmental gene therapy programs directed toward the development and commercialization of treatments for hemophilia.

Baxter obtains broad access to Chatham’s gene therapy platform, including the previously partnered hemophilia B (FIX) program, a preclinical hemophilia A (FVIII) program, and the potential future application to additional hemophilia treatments.

Baxter will make an initial payment of $70 million to acquire all of the outstanding membership interests of Chatham.

Baxter may make additional payments in the future based on specified development, regulatory and commercial milestones.

For further deal information visit Current Agreements (subscription required)

 

Related

Read: Big pharma deal news – latest deal news for top 50 pharma / big pharma companies

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

Report: Merger and Acquisition Terms and Agreements

Browse: Complete Current Partnering report catalog

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply